|
1. Sipponen P, Maaroos HI. Chronic gastritis. Scand J Gastroenterol 2015;50:657-67. doi.10.3109/00365521.2015.1019918 2. Wotherspoon AC, Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori associated gastritis and primary Bcell gastric lymphoma. Lancet 1991 9;338:1175-6. doi.10.1016/0140-6736(91)92035-z 3. Asaka M, Takeda H, Sugiyama T, Kato M. What role does H.pylori play in gastric cancer? 1 th ed. WB Saunders Publication. 1997;P.133-8. 4. Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008 a review and synthetic analysis. Lancet Oncol 2012;13:607-15. doi.10.1016/S1470-2045(12)70137-7 5. Ishaq S, Nunn L. H. pylori and gastric cancer a state of the art review. Gastroenterol Hepatol Bed Bench2015;8:6-14. 6. Gebert B, Fischer W, Haas R. The H.pylori vacuolating cytotoxin from cellular vacuolation to immunosuppressive activities. Rev Physiol Biochem Pharmacol2004;152:205-20. doi.10.1007/s10254-004-0027-3 7. Saadat I, Higashi H, Obuse C, Umeda M, Kamiya N, Saito Y, et al. H.pylori cagA targets par1/mark kinase to disrupt epithelial cell polarity. Nature2007;447:330-3. doi. 10.1038/nature05765 8. Peek RM, Vaezi MF, Falk GW, Goldblum JR, Perez GI, Richter JE, et al. Role of H. pylori cagA strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia. Int J Cancer1999;82:520-4. doi.10.1002/(SICI)1097-0215(19990812)82 9. Rawla P, Barsouk A. Epidemiology of gastric cancer global trends risk factors and prevention. Gastroenterol Rev 2019;14:26-38. doi.10.5114/pg.2018.80001 10. Khoshdel AR, Ziaei M, Ghaffari HR, Azadi S, Alimohamadi Y. [The prediction number of new cases and death of gastric cancer among Iranian military community during 2007-19]. Mult Cancer Inv2018;02:14-9. (Persian). doi.10.30699/acadpub.mci.2.2.14 11. Stanley W, Ashley JM. Daly stomatch in seymourI schwartz principle of surg. 7th ed. Sunders Publication.1999;P.1201-6. 12. Hemati S, Rahmatian A, Talee G, Bastani E, Rahmatian A, Shams M, et al. Prevalence of H.pylori and Its seasonality in Ilam Iran. JJBS2021;14:187- 9. 13. Jang BG, Kim WH. Molecular pathology of gastric carcinoma. Pathobiology 2011;78:302-10. doi.10.1159/000321703 14. Gilley D, Tanaka H, Hande MP, Kurimasa A, Li GC, Oshimura M, et al. DNA PKcs is critical for telomere capping. Proc Natl Acad Sci USA 2001; 98:15084-8. doi.10.1073/pnas.261574698 15. Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE, et al. Dna repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000;404:510-4. doi.10.1038/35006670 16. Ferguson DO, Alt FW. DNA double strand break repair and chromosomal translocation lessons from animal models. Oncogene 2001;20: 5572-9. doi.10.1038/sj.onc.1204767 17. Gao Y, Ferguson DO, Xie W, Manis JP, Sekiguchi JA, Frank KM, et al. Interplay of p53 and DNA repair protein XRCC4 in tumorigenesis genomic stability and development. Nature 2000;404:897-900. doi.10.1038/35009138 18. Zhu C, Mills KD, Ferguson DO, Lee C, Manis J, Fleming J, et al. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002;109:811-21. doi.10.1016/s0092-8674(02)00770-5 19. Pfeiffer P, Goedecke W, Kuhfittig S, Obe G. Pathways of DNA double strand break repair and their impact on the prevention and formation of chromosomal aberrations. Cyt Gen Res 2004;104:7-13. doi.10.1159/000077460 20. Mills KD, Ferguson DO, Alt FW. The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev2003;194:77-95. doi.10.1034/j.1600-065x.2003.00060.x 21. Manxhuka S, Telaku S, Devolli E, Ahmetaj H, Sahatciu V, Kerliu A, et al. H.pylori gastritis updated Sydney classification applied in our material. Prilozi2009;30:45-60. 22. Kim JJ, Tao H, Carloni E, Leung WK, Graham DY, Sepulveda AR. H.pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology2002;123:542-53. doi.10.1053/gast.2002.34751 23. Malfertheiner P, Megraud F, Omorain CA, Atherton J, Axon ATR, Bazzoli F, et al. Management of H.pylori infection the maastricht florence consensus report. Gut 2012;61:646-64. doi.10.1136/gutjnl-2012-302084 24. Wong BCY, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. H. pylori eradication to prevent gastric cancer in a high risk region of china a randomized controlled trial. J Am Med Assoc 2004;291:187-94. doi.10.3748/wjg.v12.i11.1671 25. Kidane D, Murphy DL, Sweasy JB. Accumulation of abasic sites induces genomic instability in normal human gastric epithelial cells during H.pylori infection. Oncogenesis 2014;3:24-9. doi.10.1038/oncsis.2014.42 26. Tan P, Yeoh KG. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology 2015;149:1153-62. doi.10.1053/j.gastro.2015.05.059 27. Li N, Xie C, Lu NH. P53 a potential predictor of H.pylori infection associated gastric carcinogenesis? Oncotarget 2016;7:66276-86. doi.10.18632/oncotarget.11414 28. Zaika AI, Wei J, Noto JM, Peek RM. Microbial regulation of p53 tumor suppressor. Plos Pathol 2015;11:1005099. doi.10.1371/journal.ppat.1005099 29.
|
